Carol Cheli currently serves as the principal consultant for Cheli Strategic Clinical & Medical Affairs Consulting. In this role, she uses her extensive experience in Medical Affairs and Clinical Development in both pharmaceutical and diagnostic industries. She also serves as a Board Director for BacterioScan, Inc, Prior to her current role, Cheli worked as Executive Director of Medical Affairs at Allergan where she focused on strategic plans, tactical implementation, product launches and licensing/acquisitions. She has also held leadership roles in Scientific and Medical Affairs at Boehringer-Ingelheim Pharmaceuticals and Bayer Health Care R&D Diagnostics. She earned her MSc from New York Medical College and her BSc from Mercy College.